Regulation of transcription factors by protein degradation

Cellular and Molecular Life Sciences

Volumn 57, Issue 8-9, 2000, Pages 1207-1219

  Desterro, J M P ^a   Rodriguez, M S ^a   Hay, R T ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Protein degradation; SUMO 1; Transcription; Ubiquitin

Indexed keywords

PROTEASOME; TRANSCRIPTION FACTOR;

GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN STABILITY; REVIEW; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0033837127     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000760     Document Type: Review

References (114)

1. 1 Goldstein G., Scheid M., Hammerling U., Schlesinger D. H., Niall H. D. and Boyse E. A. (1975) Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc. Natl. Acad. Sci. USA 72: 11-15
2. 2 Hershko A. and Ciechanover A. (1998) The ubiquitin system. Annu. Rev. Biochem. 67: 425-479
3. 3 Koegl M., Hoppe T., Schlenker S., Ulrich H. D., Mayer T. U. and Jentsch S. (1999) A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96: 635-644
4. 4 Groll M., Ditzel L., Lowe J., Stock D., Bochtler M., Bartunik H. D. et al. (1997) Structure of 20S proteasome from yeast at 2.4 angstrom resolution. Nature 386: 463-471
5. 5 Baumeister W., Walz J., Zuhl F. and Seemuller E. (1998) The proteasome: paradigm of a self-compartmentalizing protease. Cell 92: 367-380
6. 6 Groettrup M., Ruppert T., Kuehn L., Seeger M., Standera S., Koszinowski U. et al. (1995) The interferon-γ-inducible 11s-regulator (Pa28) and the Lmp2/Lmp7 subunits govern the peptide production by the 20s-proteasome in vitro. J. Biol. Chem. 270: 23808-23815
7. 7 Groettrup M., Kraft R., Kostka S., Standera S., Stohwasser R. and Kloetzel P. M. (1996) A 3rd interferon-γ-induced subunit exchange in the 20s proteasome. Eur. J. Immunol. 26: 863-869
8. 8 Groettrup M., Soza A., Kuckelkorn U. and Kloetzel P. M. (1996) Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today 17: 429-435
9. 9 Lee D. H. and Goldberg A. L. (1998) Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8: 397-403
10. 10 Wilkinson K. D. (1997) Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11: 1245-1256
11. 11 D'Andrea A. and Pellman D. (1998) Deubiquitinating enzymes: a new class of biological regulators. Crit. Rev. Biochem. Mol. Biol. 33: 337-352
12. 12 Hodges M., Tissot C. and Freemont P. S. (1998) Protein regulation: tag wrestling with relatives of ubiquitin. Curr. Biol. 8: R749-R752
13. 13 Desterro J. M. P., Rodriguez M. S., Kemp G. D. and Hay R. T. (1999) Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274: 10618-10624
14. 14 Gong L., Li B., Millas S. and Yeh E. T. (1999) Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex. FEBS Lett. 448: 185-189
15. 15 Okuma T., Honda R., Ichikawa G., Tsumagari N. and Yasuda H. (1999) In vitro SUMO-I modification requires two enzymatic steps, E1 and E2. Biochem. Biophys. Res. Commun. 254: 693-698
16. 16 Johnson E. S., Schwienhorst I., Dohmen R. J. and Blobel G. (1997) The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J. 16: 5509-5519
17. 17 Johnson E. S. and Blobel G. (1997) Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272: 26799-26802
18. 18 Schwarz S. E., Matuschewski K., Liakopoulos D., Scheffner M. and Jentsch S. (1998) The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc. Natl. Acad. Sci. USA 95: 560-564
19. 19 Saitoh H., Sparrow D. B., Shiomi T., Pu R. T., Nishimoto T., Mohun T. J. et al. (1998) Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr. Biol. 8: 121-124
20. 20 Desterro J. M. P., Thomson J. and Hay R. T. (1997) Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417: 297-300
21. 21 Desterro J. M. P., Rodriguez M. S. and Hay R. T. (1998) SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 2: 233-239
22. 22 Duprez E., Saurin A. J., Desterro J. M., Lallemand-Breitenbach V., Howe K., Boddy et al. (1999) SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J. Cell Sci. 112: 381-393
23. 23 Rodriguez M. S., Desterro J. M., Lain S., Midgley C. A., Lane D. P. and Hay R. T. (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18: 6455-6461
24. 24 Johnson E. S. and Blobel G. (1999) Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. J. Cell Biol. 147: 981-994
25. 25 Liu Q., Yuan Y. C., Shen B., Chen D. J. and Chen Y. (1999) Conformational flexibility of a ubiquitin conjugating enzyme (E2). Biochemistry 38: 1415-1425
26. 26 Li S. J. and Hochstrasser M. (1999) A new protease required for cell-cycle progression in yeast. Nature 398: 246-251
27. 27 Hay R. T., Vuillard L., Desterro J. M. P. and Rodriguez M. S. (1999) Control of NF-κB transcriptional activation by signal induced proteolysis of IκBα. Phil. Trans. Roy. Soc. 354: 1601-1609
28. 28 LeBail O., Schmidt-Ullrich R. and Israel A. (1993) Promoter analysis of the gene encoding the IκBα/mad3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family. EMBO J. 12: 5043-5049
29. 29 Sun S. C., Ganchi P. A., Ballard D. W. and Greene W. C. (1993) NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259: 1912-1915
30. 30 Rodriguez M. S., Thompson J., Hay R. T. and Dargemont C. (1999) Nuclear retention of IκBα protects it from signal-induced degradation and inhibits NF-κB transcriptional activation. J. Biol. Chem. 274: 9108-9115
31. 31 Arenzana-Seisdedos F., Thompson J., Rodriguez M. S., Bachelerie F., Thomas D. and Hay R. T. (1995) Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell. Biol. 15: 2689-2696
32. 32 Arenzana-Seisdedos F., Turpin P., Rodriguez M., Thomas D., Hay R. T., Virelizier J. L. et al. (1997) Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm. J. Cell Sci. 110: 369-378
33. 33 Johnson C., Van Antwerp D. and Hope T. J. (1999) An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα EMBO J. 18: 6682-6693
34. 34 Karin M. (1999) The beginning of the end: IκB kinase (IKK) and NF-κB activation. J. Biol. Chem. 274: 27339-27342
35. 35 Chen Z. J., Hagler J., Palombella V. J., Melandri F., Scherer D., Ballard D. et al. (1995) Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9: 1586-1597
36. 36 Alkalay I., Yaron A., Hatzubai A., Orian A., Ciechanover A. and Ben-Neriah Y. (1995) Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 92: 10599-10603
37. 37 Roff M., Thomson J., Rodriguez M. S., Jacque J.-M., Baleux F., Arenzana-Seisdedos F. et al. (1996) Role of IκBα ubiquitination in signal-induced activation of NF-κB in vivo. J. Biol. Chem. 271: 7844-7850
38. 38 Rodriguez M. S., Wright J., Thompson J., Thomas D., Baleux F., Virelizier J. L. et al. (1996) Identification of lysine residues required for signal-induced ubiquitination and degradation of IκBα in vivo. Oncogene 12: 2425-2435
39. 39 Yaron A., Hatzubai A., Davis M., Lavon I., Amit S., Manning A. M. et al. (1998) Identification of the receptor component of the IκBα-ubiquitin ligase. Nature 396: 590-594
40. 40 Winston J. T., Strack P., Beer-Romero P., Chu C. Y., Elledge S. J. and Harper J. W. (1999) The SCF β-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 13: 270-283
41. 41 Spencer E., Jiang J. and Chen Z. J. (1999) Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β-TrCP. Genes Dev. 13: 284-294
42. 42 Hatakeyama S., Kitagawa M., Nakayama K., Shirane M., Matsumoto M., Hattori K. et al. (1999) Ubiquitin-dependent degradation of IκBα is mediated by a ubiquitin ligase Skp1/Cul I/F-box protein FWD1. Proc. Natl. Acad. Sci. USA 96: 3859-3863
43. 43 Vuillard L., Nicholson J. and Hay R. T. (1999) A complex containing βTrCP recruits Cdc34 to catalyse ubiquitination of IκBα. FEBS Lett. 455: 311-314
44. 44 Jiang J. and Struhl G. (1998) Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature 391: 493-496
45. 45 Margottin F., Bour S. P., Durand H., Selig L., Benichou S., Richard V. et al. (1998) A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1: 565-574
46. 46 Latres E., Chiaur D. S. and Pagano M. (1999) The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin. Oncogene 18: 849-854
47. 47 Hart M., Concordet J. P., Lassot I., Albert I., del los Santos R., Durand H. et al. (1999) The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell. Curr. Biol. 9: 207-210
48. 48 Kitagawa M., Hatakeyama S., Shirane M., Matsumoto M., Ishida N., Hattori K. et al. (1999) An F-box protein, FWDI, mediates ubiquitin-dependent proteolysis of β-catenin. EMBO J. 18: 2401-2410
49. 49 Tan P., Fuchs S. Y., Chen A., Wu K., Gomez C., Ronai Z. et al. (1999) Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of IκBα. Mol. Cell 3: 527-533
50. 50 Kroll M., Margottin F., Kohl A., Renard P., Durand H., Concordet J. P. et al. (1999) Inducible degradation of IκBα by the proteasome requires interaction with the F-box protein h-βTrCP. J. Biol. Chem. 274: 7941-7945
51. 51 Read M. A., Brownell J. E., Gladysheva T. B., Hottelet M., Parent L. A., Coggins M. B. et al. (2000) Nedd8 modification of cul-1 activates SCF[β(TrCP)]-dependent ubiquitination of IκBα. Mol. Cell. Biol. 20: 2326-2333
52. 52 Johnson E. S., Ma P. C. M., Ota I. M. and Varshavsky A. (1995) A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 270: 17442-17456
53. 53 Lane D. P. (1992) Cancer. p53, guardian of the genome. Nature 358: 15-16
54. 54 Maki C. G., Huibregtse J. M. and Howley P. M. (1996) In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56: 2649-2654
55. 55 Bottger A., Bottger V., Sparks A., Liu W. L., Howard S. F. and Lane D. P. (1997) Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr. Biol. 7: 860-869
56. 56 Haupt Y., Maya R., Kazaz A. and Oren M. (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-303
57. 57 Kubbutat M. H. G., Jones S. N. and Vousden K. H. (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303
58. 58 Honda R., Tanaka H. and Yasuda H. (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420: 25-27
59. 59 Gostissa M., Hengstermann A., Fogal V., Sandy P., Schwarz S. E., Scheffner M. et al. (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18: 6462-6471
60. 60 Honda R. and Yasuda H. (1999) Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18: 22-27
61. 61 Midgley C. A., Desterro J. M. P., Howard S., Sparks A., Hay R. T. and Lane D. P. (2000) An N-terminal p14Arf peptide blocks Hdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19: 2312-2323
62. 62 Hsieh J. K., Chan F. S., O'Connor D. J., Mittnacht S., Zhong S. and Lu X. (1999) RB regulates the stability and the apoptotic function of p53 via MDM2. Mol. Cell 3: 181-193
63. 63 Mahajan R., Delphin C., Guan T., Gerace L. and Melchior F. (1997) A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88: 97-107
64. 64 Matunis M. and Blobel G. (1997) Novel ubiquitin-like protein modifications and targeting of the Ran GTPase activating protein RanGAP1 to the nuclear pore complex. Mol. Biol. Cell 8: 1367-1367
65. 65 Muller S., Matunis M. J. and Dejean A. (1998) Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17: 61-70
66. 66 Sternsdorf T., Jensen K. and Will H. (1997) Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PICI/SUMO-1. J. Cell Biol. 139: 1621-1634
67. 67 Roth J., Dobbelstein M., Freedman D. A., Shenk T. and Levine A. J. (1998) Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17: 554-564
68. 68 Lain S., Midgley C., Sparks A., Lane E. B. and Lane D. P. (1999) An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp. Cell Res. 248: 457-472
69. 69 Freedman D. A. and Levine A. J. (1998) Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 18: 7288-7293
70. 70 Angel P. and Karin M. (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Ada 1072: 129-157
71. 71 Karin M. and Hunter T. (1995) Transcriptional control by protein-phosphorylation: signal transmission from the cell-surface to the nucleus. Curr. Biol. 5: 747-757
72. 72 Bossy-Wetzel E., Bakiri L. and Yaniv M. (1997) Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16: 1695-1709
73. 73 Treier M., Staszewski L. M. and Bohmann D. (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78: 787-798
74. 74 Musti A. M., Treier M. and Bohmann D. (1997) Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275: 400-402
75. 75 Papavassiliou A. G., Treier M. and Bohmann D. (1995) Intramolecular signal transduction in c-Jun. EMBO J. 14: 2014-2019
76. 76 Pulverer B. J., Kyriakis J. M., Avruch J., Nikolakaki E. and Woodgett J. R. (1991) Phosphorylation of c-jun mediated by MAP kinases. Nature 353: 670-674
77. 77 Jariel-Encontre T., Pariat M., Martin F., Carillo S., Salvat C. and Piechaczyk M. (1995) Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J. Biol. Chem. 270: 11623-11627
78. 78 Ciechanover A., DiGiuseppe J. A., Bercovich B., Orian A., Richter J. D., Schwartz A. L. et al. (1991) Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc. Natl. Acad. Sci. USA 88: 139-143
79. 79 Tsurumi C., Ishida N., Tamura T., Kakizuka A., Nishida E., Okumura E. et al. (1995) Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. Mol. Cell. Biol. 15: 5682-5687
80. 80 Stancovski I., Gonen H., Orian A., Schwartz A. L. and Ciechanover A. (1995) Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Mol. Cell. Biol. 15: 7106-7116
81. 81 Morin P. J. (1999) β-catenin signaling and cancer. Bioessays 21: 1021-1030
82. 82 Clevers H. and van de Wetering M. (1997) TCF/LEF factor earn their wings. Trends Genet. 13: 485-489
83. 83 Su L. K., Vogelstein B. and Kinzler K. W. (1993) Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737
84. 84 Rubinfeld B., Souza B., Albert I., Muller O., Chamberlain S. H., Masiarz F. R. et al. (1993) Association of the APC gene product with beta-catenin. Science 262: 1731-1734
85. 85 Hemmings B. A. (1997) Akt signaling: linking membrane events to life and death decisions. Science 275: 628-630
86. 86 Fagotto F., Gluck U. and Gumbiner B. M. (1998) Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of β-catenin. Curr. Biol. 8: 181-190
87. 87 He T. C., Sparks A. B., Rago C., Hermeking H., Zawel L., da Costa L. T. et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512
88. 88 Tetsu O. and McCormick F. (1999) β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426
89. 89 Korinek V., Barker N., Morin P. J., van Wichen D., de Weger R., Kinzler K. W. et al. (1997) Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science 275: 1784-1787
90. 90 Morin P. J., Sparks A. B., Korinek V., Barker N., Clevers H., Vogelstein B. et al. (1997) Activation of β-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790
91. 91 Wang G. L., Jiang B. H., Rue E. A. and Semenza G. L. (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92: 5510-5514
92. 92 Carmeliet P., Dor Y., Herbert J. M., Fukumura D., Brusselmans K., Dewerchin M. et al. (1998) Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490
93. 93 An W. G., Kanekal M., Simon M. C., Maltepe E., Blagosklonny M. V. and Neckers L. M. (1998) Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392: 405-408
94. 94 Salceda S. and Caro J. (1997) Hypoxia-inducible factor 1 α (HIF-1 α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272: 22642-22647
95. 95 Huang L. E., Gu J., Schau M. and Bunn H. F. (1998) Regulation of hypoxia-inducible factor 1 alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95: 7987-7992
96. 96 Kaelin W. G. Jr and Maher E. R. (1998) The VHL tumour-suppressor gene paradigm. Trends Genet. 14: 423-426
97. 97 Maxwell P. H., Wiesener M. S., Chang G. W., Clifford S. C., Vaux E. C., Cockman M. E. et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275
98. 98 Stebbins C. E., Kaelin W. G. Jr and Pavletich N. P. (1999) Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284: 455-461
99. 99 Lonergan K. M., Iliopoulos O., Ohh M., Kamura T., Conaway R. C., Conaway J. W. et al. (1998) Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Mol. Cell. Biol. 18: 732-741
100. 100 Kamura T., Koepp D. M., Conrad M. N., Skowyra D., Moreland R. J., Iliopoulos O. et al. (1999) Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284: 657-661
101. 101 Kaelin W. G. Jr (1999) Cancer. Many vessels, faulty gene. Nature 399: 203-204
102. 102 Marti A., Wirbelauer C., Scheffner M. and Krek W. (1999) Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat. Cell Biol. 1: 14-19
103. 103 Huibregtse J. M., Scheffner M. and Howley P. M. (1993) Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53 and ubiquitination of associated proteins. Mol. Cell. Biol. 13: 4918-4927
104. 104 Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J. and Howley P. M. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136
105. 105 Dobner T., Horikoshi N., Rubenwolf S. and Shenk T. (1996) Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272: 1470-1473
106. 106 Stark G. R., Kerr I. M., Williams B. R., Silverman R. H. and Schreiber R. D. (1998) How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264
107. 107 Didcock L., Young D. F., Goodbourn S. and Randall R. E. (1999) The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73: 9928-9933
108. 108 Young D. F., Didcock L., Goodburn S. and Randall R. E. (2000) Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269: 383-390
109. 109 Everett R. D. and Maul G. G. (1994) HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 13: 5062-5069
110. 110 Everett R. D., Freemont P., Saitoh H., Dasso M., Orr A., Kathoria M. et al. (1998) The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110-and proteasome-dependent loss of several PML isoforms. J. Virol. 72: 6581-6591
111. 111 Everett R. D., Earnshaw W. C., Findlay J. and Lomonte P. (1999) Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. EMBO J. 18: 1526-1538
112. 112 Doucas V., Ishov A. M., Romo A., Juguilon H., Weitzman M. D., Evans R. M. et al. (1996) Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10: 196-207
113. 113 Leppard K. N. and Everett R. D. (1999) The adenovirus type 5 E1b 55K and E4 Orf3 proteins associate in infected cells and affect ND10 components. J. Gen. Virol. 80: 997-1008
114. 114 Mosialos G. (1997) The role of Rel/NF-κB proteins in viral oncogenesis and the regulation of viral transcription. Semin. Cancer Biol. 8: 121-129